These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38829967)

  • 41. COVID-19 and liver cancer: lost patients and larger tumours.
    Geh D; Watson R; Sen G; French JJ; Hammond J; Turner P; Hoare T; Anderson K; McNeil M; McPherson S; Masson S; Dyson J; Donnelly M; MacDougal L; Patel P; Hudson M; Anstee QM; White S; Robinson S; Pandanaboyana S; Walker L; McCain M; Bury Y; Raman S; Burt A; Parkinson D; Haugk B; Darne A; Wadd N; Asghar S; Mariappan L; Margetts J; Stenberg B; Scott J; Littler P; Manas DM; Reeves HL
    BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35450934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
    Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
    J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocellular carcinoma - United States, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
    Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
    Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
    Rudnick SR; Ugwuegbu J; Soufleris SJ; Bundy R; Dharod A; Russo MW
    Dig Dis Sci; 2023 May; 68(5):1791-1796. PubMed ID: 36562886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
    Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
    J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States.
    Ozturk NB; Pham HN; Mouhaffel R; Ibrahim R; Alsaqa M; Gurakar A; Saberi B
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
    Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality.
    Persson EC; Schwartz LM; Park Y; Trabert B; Hollenbeck AR; Graubard BI; Freedman ND; McGlynn KA
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):415-21. PubMed ID: 23307533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Zou WY; El-Serag HB; Sada YH; Temple SL; Sansgiry S; Kanwal F; Davila JA
    Dig Dis Sci; 2018 May; 63(5):1173-1181. PubMed ID: 29508165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States.
    Mahale P; Shiels MS; Lynch CF; Chinnakotla S; Wong LL; Hernandez BY; Pawlish KS; Li J; Alverson G; Schymura MJ; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):513-520. PubMed ID: 33199438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
    Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.
    Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.